SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 58.45 |
| Enterprise Value ($M) | 55.56 |
| Book Value ($M) | -0.33 |
| Book Value / Share | -0.02 |
| Price / Book | -176.06 |
| NCAV ($M) | -12.09 |
| NCAV / Share | -0.89 |
| Price / NCAV | -4.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.50 |
| Return on Assets (ROA) | -0.12 |
| Return on Equity (ROE) | -36.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.69 |
| Current Ratio | 0.69 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 13.18 |
| Assets | 24.93 |
| Liabilities | 25.27 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | West Elk Partners, LP | 6.49 | -19.28 | |
| 13D/A | New Enterprise Associates 14, L.P. | 12.60 | -94.10 | |
| 13G | Tocqueville Asset Management L.p. | 5.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,129 | 9,185 | 34.07 | |
| 1,947 | 5,793 | 33.61 | |
| 6,190 | 22,525 | 27.48 | |
| 6,322 | 9,918 | 63.74 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRDF – Cardiff Oncology, Inc. | CRIS – Curis, Inc. |
| CRVO – CervoMed Inc. | CSCI – COSCIENS Biopharma Inc. |
| CTXR – Citius Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io